Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa.

Lawn SD, Myer L, Edwards D, Bekker LG, Wood R.

AIDS. 2009 Aug 24;23(13):1717-25. doi: 10.1097/QAD.0b013e32832d3b6d.

2.

Effect of early versus deferred antiretroviral therapy for HIV on survival.

Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Goedert JJ, Benson CA, Collier AC, Van Rompaey SE, Crane HM, McKaig RG, Lau B, Freeman AM, Moore RD; NA-ACCORD Investigators..

N Engl J Med. 2009 Apr 30;360(18):1815-26. doi: 10.1056/NEJMoa0807252. Epub 2009 Apr 1.

3.

Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis.

Palaci M, Dietze R, Hadad DJ, Ribeiro FK, Peres RL, Vinhas SA, Maciel EL, do Valle Dettoni V, Horter L, Boom WH, Johnson JL, Eisenach KD.

J Clin Microbiol. 2007 Dec;45(12):4064-6. Epub 2007 Oct 10.

4.

Treatment outcomes of patients with HIV and tuberculosis.

Nahid P, Gonzalez LC, Rudoy I, de Jong BC, Unger A, Kawamura LM, Osmond DH, Hopewell PC, Daley CL.

Am J Respir Crit Care Med. 2007 Jun 1;175(11):1199-206. Epub 2007 Feb 8.

5.

HIV co-infection, CD4 cell counts and clinical correlates of bacillary density in pulmonary tuberculosis.

Mugusi F, Villamor E, Urassa W, Saathoff E, Bosch RJ, Fawzi WW.

Int J Tuberc Lung Dis. 2006 Jun;10(6):663-9.

PMID:
16776454
6.

Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.

Gulick RM, Ribaudo HJ, Shikuma CM, Lustgarten S, Squires KE, Meyer WA 3rd, Acosta EP, Schackman BR, Pilcher CD, Murphy RL, Maher WE, Witt MD, Reichman RC, Snyder S, Klingman KL, Kuritzkes DR; AIDS Clinical Trials Group Study A5095 Team..

N Engl J Med. 2004 Apr 29;350(18):1850-61.

7.

Human immunity to M. tuberculosis: T cell subsets and antigen processing.

Boom WH, Canaday DH, Fulton SA, Gehring AJ, Rojas RE, Torres M.

Tuberculosis (Edinb). 2003;83(1-3):98-106. Review.

PMID:
12758197
8.

Revised international definitions in tuberculosis control.

World Health Organization.; International Union Against Tuberculosis and Lung Disease.; Royal Netherlands Tuberculosis Association..

Int J Tuberc Lung Dis. 2001 Mar;5(3):213-5. No abstract available.

PMID:
11326818
9.

Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients.

Murray J, Sonnenberg P, Shearer SC, Godfrey-Faussett P.

Am J Respir Crit Care Med. 1999 Mar;159(3):733-40.

PMID:
10051244
10.

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

Narita M, Ashkin D, Hollender ES, Pitchenik AE.

Am J Respir Crit Care Med. 1998 Jul;158(1):157-61.

PMID:
9655723
11.

Incidence and significance of acid-fast bacilli in sputum smears at the end of antituberculous treatment.

Vidal R, Martin-Casabona N, Juan A, Falgueras T, Miravitlles M.

Chest. 1996 Jun;109(6):1562-5.

PMID:
8769512
12.

Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months.

Perriƫns JH, St Louis ME, Mukadi YB, Brown C, Prignot J, Pouthier F, Portaels F, Willame JC, Mandala JK, Kaboto M, et al.

N Engl J Med. 1995 Mar 23;332(12):779-84.

Supplemental Content

Support Center